BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng X, Li J, Fan Q, Zhao X, Chen K. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca2+ overload via the microRNA-346-3p/CaMKIId axis. Int J Cardiol 2021;338:185-95. [PMID: 33731281 DOI: 10.1016/j.ijcard.2021.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Suades R. miRNA-346-3p/CaMKIId axis: In'DEX'ing a new pharmacological strategy for cardioprotection. Int J Cardiol 2021;334:102-3. [PMID: 33892044 DOI: 10.1016/j.ijcard.2021.04.026] [Reference Citation Analysis]
2 Xie MY, Hou LJ. Dexmedetomidine down-regulates lncRNA MALAT1 to attenuate myocardial ischemia reperfusion-induced injury by increasing miR-346. Int J Cardiol 2021;334:104. [PMID: 33905806 DOI: 10.1016/j.ijcard.2021.04.040] [Reference Citation Analysis]
3 Wu C, Liu B, Wang R, Li G. The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years. Front Cardiovasc Med 2022;8:809580. [DOI: 10.3389/fcvm.2021.809580] [Reference Citation Analysis]
4 Peng L, Lei Z, Rao Z, Yang R, Zheng L, Fan Y, Luan F, Zeng N. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis. Phytomedicine 2021;93:153798. [PMID: 34673348 DOI: 10.1016/j.phymed.2021.153798] [Reference Citation Analysis]
5 Xiong B, Wang Y, Liu Y, Wu C, Chen J. The circulating LncRNA SNHG15/miR-346 axis may be a potential biomarker of cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury. Int J Cardiol 2021;334:30. [PMID: 33933513 DOI: 10.1016/j.ijcard.2021.04.057] [Reference Citation Analysis]
6 Song X. New mechanisms uncovered for the cardioprotective effects of dexmedetomidine. Int J Cardiol 2021;336:97. [PMID: 33933508 DOI: 10.1016/j.ijcard.2021.04.059] [Reference Citation Analysis]